Lisata Therapeutics, Inc.
LSTA· Nasdaq
LSTALisata Therapeutics, Inc.
Released Aug 8, 2013, after the close
10-Q filed Aug 8, 2013, 39 days after period end · 0000320017-13-000071
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2012 | Q2 2011 | Q2 2010 | Q2 2009 |
|---|---|---|---|---|
| Revenue | — | $3.37M | $2.21M | $19.41M |
| Net Income | -$8.58K | -$20.51M | -$10.61M | -$5.37M |
| EPS Diluted | -$0.46 |
Lisata Therapeutics, Inc. · CIK 320017 · Engraved from SEC EDGAR
| -$1.53 |
| -$0.13 |
| -$0.11 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
